<SEC-DOCUMENT>0000933430-21-000002-index.html : 20210107
<SEC-HEADER>0000933430-21-000002.hdr.sgml : 20210107
<ACCEPTANCE-DATETIME>20210107111053
ACCESSION NUMBER:		0000933430-21-000002
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210107
DATE AS OF CHANGE:		20210107

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Clearside Biomedical, Inc.
		CENTRAL INDEX KEY:			0001539029
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				452437375
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89527
		FILM NUMBER:		21513401

	BUSINESS ADDRESS:	
		STREET 1:		900 NORTH POINT PARKWAY
		STREET 2:		SUITE 200
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30005
		BUSINESS PHONE:		678-270-3631

	MAIL ADDRESS:	
		STREET 1:		900 NORTH POINT PARKWAY
		STREET 2:		SUITE 200
		CITY:			ALPHARETTA
		STATE:			2Q
		ZIP:			30005

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WHITMORE BRADFORD T
		CENTRAL INDEX KEY:			0000933430
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	MAIL ADDRESS:	
		STREET 1:		1603 ORRINGTON AVE., STE 900
		CITY:			EVANSTON
		STATE:			IL
		ZIP:			60201
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>clsd13g3.txt
<DESCRIPTION>SCHEDULE 13G AMENDMENT
<TEXT>
Document 1 - file: clsd13g3.txt

</DOCUMENT>
</SEC-DOCUMENT>